相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lessons from immunotherapy for Alzheimer disease
Yan-Jiang Wang
NATURE REVIEWS NEUROLOGY (2014)
Antiamyloid Therapy for Alzheimer's Disease - Are We on the Right Road?
Eric Karran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Stephen Salloway et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies
Fabrizio Piazza et al.
ANNALS OF NEUROLOGY (2013)
Enhanced Proteolytic Clearance of Plasma Aβ by Peripherally Administered Neprilysin Does Not Result in Reduced Levels of Brain Aβ in Mice
John R. Walker et al.
JOURNAL OF NEUROSCIENCE (2013)
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
Richard Dodel et al.
LANCET NEUROLOGY (2013)
被撤回的出版物: Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease (Retracted article. See vol. 523, 2015)
Herve Rhinn et al.
NATURE (2013)
PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases
Mathea Pietri et al.
NATURE MEDICINE (2013)
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Elizabeth M. Bradshaw et al.
NATURE NEUROSCIENCE (2013)
Deciphering the mechanism underlying late-onset Alzheimer disease
Dimitrije Krstic et al.
NATURE REVIEWS NEUROLOGY (2013)
Safety and biomarker effects of Solanezumab in patients with Alzheimer's disease
Martin Farlow et al.
ALZHEIMERS & DEMENTIA (2012)
Sustained levels of antibodies against Aβ in amyloid-rich regions of the CNS following intravenous dosing in human APP transgenic mice
Frederique Bard et al.
EXPERIMENTAL NEUROLOGY (2012)
Human Serum Albumin Can Regulate Amyloid-β Peptide Fiber Growth in the Brain Interstitium IMPLICATIONS FOR ALZHEIMER DISEASE
Helen F. Stanyon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Autoreactive-Aβ antibodies promote APP β-secretase processing
Juan Deng et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
Reisa Sperling et al.
LANCET NEUROLOGY (2012)
ASSOCIATION OF ALZHEIMER DISEASE PATHOLOGY WITH ABNORMAL LIPID METABOLISM: THE HISAYAMA STUDY
Gerson T. Lesser
NEUROLOGY (2012)
Amyloid β Levels in Human Red Blood Cells
Takehiro Kiko et al.
PLOS ONE (2012)
Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver
Neha Sehgal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab
Christopher Carlson et al.
ALZHEIMERS & DEMENTIA (2011)
Immunotherapy for Alzheimer's disease
D. Morgan
JOURNAL OF INTERNAL MEDICINE (2011)
Naturally Occurring Autoantibodies against β-Amyloid: Investigating Their Role in Transgenic Animal and In Vitro Models of Alzheimer's Disease
Richard Dodel et al.
JOURNAL OF NEUROSCIENCE (2011)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj et al.
NATURE GENETICS (2011)
Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease
J. Li et al.
NEUROLOGY (2011)
Autoantibodies recognizing native MOG are closely associated with active demyelination but not with neuroinflammation in chronic EAE
Shin Ohtani et al.
NEUROPATHOLOGY (2011)
Molecular basis for amyloid-β polymorphism
Jacques-Philippe Colletier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer's disease
Yan-Jiang Wang et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Conformations and Biological Activities of Amyloid Beta Peptide 25-35
L. Millucci et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2010)
Circulating neprilysin clears brain amyloid
Yinxing Liu et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2010)
AMYLOID-TARGETED THERAPEUTICS IN ALZHEIMER'S DISEASE: USE OF HUMAN ALBUMIN IN PLASMA EXCHANGE AS A NOVEL APPROACH FOR Aβ MOBILIZATION
Merce Boada et al.
DRUG NEWS & PERSPECTIVES (2009)
Expression of Neprilysin in Skeletal Muscle Reduces Amyloid Burden in a Transgenic Mouse Model of Alzheimer Disease
Yinxing Liu et al.
MOLECULAR THERAPY (2009)
Intramuscular delivery of a single chain antibody gene reduces brain Aβ burden in a mouse model of Alzheimer's disease
Yan-Jiang Wang et al.
NEUROBIOLOGY OF AGING (2009)
Fatty acids, lipid metabolism and Alzheimer pathology
Carlijn R. Hooijmans et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system
Ryan N. Dilger et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
In vitro and in vivo degradation of Aβ peptide by peptidases coupled to erythrocytes
Yinxing Liu et al.
PEPTIDES (2007)
Insulin facilitates the hepatic clearance of plasma amyloid β-peptide (1-40) by intracellular translocation of low-density lipoprotein receptor-related protein 1 (LRP-1) to the plasma membrane in hepatocytes
Chihiro Tamaki et al.
MOLECULAR PHARMACOLOGY (2007)
ABCA1, from pathology to membrane function
Ana Zarubica et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2007)
Peripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes
Joseph Rogers et al.
NEUROBIOLOGY OF AGING (2006)
Amyloid-β peptide remnants in AN-1792-immunized Alzheimer's disease patients -: A biochemical analysis
R. Lyle Patton et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice
R Koldamova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Clinical effects of Aβ immunization (AN1792) in patients with AD in an interrupted trial
S Gilman et al.
NEUROLOGY (2005)
Moderate renal impairment and risk of dementia among older adults: The cardiovascular health cognition study
SL Seliger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
RAGE (Yin) versus LRP (Yang) balance regulates Alzheimer amyloid β-peptide clearance through transport across the blood-brain barrier
R Deane et al.
STROKE (2004)
22R-Hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid β secretion
RP Koldamova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Aβ levels
H Fukumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Serum creatinine levels correlate with plasma amyloid β protein
Z Arvanitakis et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2002)
Brain to plasma amyloid-β efflux:: a measure of brain amyloid burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
SCIENCE (2002)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Modulation of amyloid β-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway
DE Kang et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
